Balyasny Asset Management’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-105,578
| Closed | -$727K | – | 3147 |
|
|
2024
Q4 | $727K | Buy |
105,578
+5,209
| +5% | +$35.8K | ﹤0.01% | 2061 |
|
|
2024
Q3 | $740K | Buy |
+100,369
| New | +$938K | ﹤0.01% | 2084 |
|
|
2024
Q2 | – | Sell |
-183,246
| Closed | -$2.53M | – | 2946 |
|
|
2024
Q1 | $2.53M | Buy |
+183,246
| New | +$2.86M | ﹤0.01% | 1470 |
|
|
2023
Q4 | – | Sell |
-76,974
| Closed | -$1.63M | – | 2772 |
|
|
2023
Q3 | $1.63M | Sell |
76,974
-51,119
| -40% | -$1.33M | ﹤0.01% | 1428 |
|
|
2023
Q2 | $4.25M | Buy |
+128,093
| New | +$4.72M | 0.01% | 1122 |
|
|
2023
Q1 | – | Sell |
-147,653
| Closed | -$6.23M | – | 2997 |
|
|
2022
Q4 | $6.23M | Buy |
+147,653
| New | +$5.68M | 0.02% | 933 |
|
|
2022
Q2 | – | Sell |
-75,186
| Closed | -$3.6M | – | 3041 |
|
|
2022
Q1 | $3.6M | Sell |
75,186
-44,596
| -37% | -$2.21M | 0.01% | 1093 |
|
|
2021
Q4 | $6.08M | Buy |
+119,782
| New | +$5.32M | 0.02% | 789 |
|
|
2019
Q4 | – | Sell |
-41,879
| Closed | -$1.78M | – | 1385 |
|
|
2019
Q3 | $1.78M | Buy |
41,879
+9,754
| +30% | +$409K | 0.01% | 732 |
|
|
2019
Q2 | $1.58M | Buy |
+32,125
| New | +$1.63M | 0.01% | 950 |
|
|
2019
Q1 | – | Sell |
-33,970
| Closed | -$2.08M | – | 1565 |
|
|
2018
Q4 | $2.08M | Buy |
+33,970
| New | +$2.29M | 0.02% | 710 |
|
|
2018
Q1 | – | Sell |
-7,334
| Closed | -$500K | – | 2212 |
|
|
2017
Q4 | $500K | Sell |
7,334
-9,501
| -56% | -$615K | ﹤0.01% | 1558 |
|
|
2017
Q3 | $1.03M | Sell |
16,835
-45,626
| -73% | -$2.8M | ﹤0.01% | 1156 |
|
|
2017
Q2 | $3.92M | Buy |
+62,461
| New | +$3.56M | 0.02% | 809 |
|
|
2015
Q4 | – | Sell |
-125,247
| Closed | -$5.17M | – | 1379 |
|
|
2015
Q3 | $5.17M | Buy |
+125,247
| New | +$5.38M | 0.04% | 519 |
|
|
2015
Q2 | – | Sell |
-422,512
| Closed | -$25.4M | – | 1271 |
|
|
2015
Q1 | $25.4M | Buy |
+422,512
| New | +$21.5M | 0.21% | 153 |
|
|
2014
Q3 | – | Sell |
-94,489
| Closed | -$6.99M | – | 819 |
|
|
2014
Q2 | $6.99M | Buy |
94,489
+79,489
| +530% | +$6.26M | 0.08% | 315 |
|
|
2014
Q1 | $1.24M | Buy |
+15,000
| New | +$1.32M | 0.01% | 514 |
|
|
2013
Q4 | – | Sell |
-82,593
| Closed | -$7.91M | – | 590 |
|
|
2013
Q3 | $7.91M | Buy |
82,593
+13,208
| +19% | +$1.12M | 0.11% | 262 |
|
|
2013
Q2 | $4.24M | Buy |
+69,385
| New | +$3.85M | 0.07% | 326 |
|
Other funds holding NUS
PGCM
Balyasny Asset Management's NUS Position: Q1 2025 in Review
Balyasny Asset Management sold out of Nu Skin (NUS) in Q1 2025, closing a stake of 105,578 shares — an estimated $727K sold.
Balyasny Asset Management first reported a position in NUS in Q2 2013 and held it in 20 quarters. The position peaked at $25.4M in Q1 2015. 195 funds tracked by Wall St. Rank hold NUS as of Q1 2025.
- Balyasny Asset Management reported no remaining Nu Skin position as of Q1 2025 after selling out during the quarter.
- Balyasny Asset Management sold 105,578 Nu Skin shares in Q1 2025, an estimated $727K.
- Balyasny Asset Management first reported a position in Nu Skin in Q2 2013 and held it in 20 quarters.
- Balyasny Asset Management's Nu Skin position peaked at $25.4M in Q1 2015.
- 195 funds tracked by Wall St. Rank held Nu Skin as of Q1 2025.
Based on Balyasny Asset Management's 13F filing for Q1 2025, filed 15 May 2025.